Premium
In vitro Inhibition of CYP3A4 Metabolism and P‐Glycoprotein‐Mediated Transport by Trade Herbal Products
Author(s) -
Hellum Bent H.,
Nilsen Odd Georg
Publication year - 2008
Publication title -
basic and clinical pharmacology and toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.805
H-Index - 90
eISSN - 1742-7843
pISSN - 1742-7835
DOI - 10.1111/j.1742-7843.2008.00227.x
Subject(s) - cyp3a4 , in vitro , p glycoprotein , chemistry , metabolism , pharmacology , biochemistry , biology , cytochrome p450 , multiple drug resistance , antibiotics
Abstract: Extracts of six commonly used commercially available herbal products, St. John's wort, common valerian, common sage, Ginkgo biloba , Echinacea purpurea and horse chestnut were investigated for their in vitro inhibitory potential of CYP3A4 mediated metabolism and P‐glycoprotein efflux transport activity. C‐DNA baculovirus expressed CYP3A4 and Caco‐2 cells were used. Ketoconazole and verapamil were applied as positive control inhibitors, respectively. A validated high‐performance liquid chromatography methodology was used to quantify the formation of 6‐OH‐testosterone and scintillation counting was used to quantify the transport of 3 H‐digoxin. All the investigated herbs inhibited CYP3A4 activity. St. John's wort was the strongest inhibiting herb with an IC 50 value of 15.4 µg/ml, followed by common sage, Ginkgo biloba , common valerian, horse chestnut and Echinacea purpurea . All herbs also inhibited P‐glycoprotein activity. Ginkgo biloba was the strongest inhibiting herb, inhibiting the net digoxin flux with an IC 50 value of 23.6 µg/ml, followed by St. John's wort, horse chestnut, common sage, common valerian and Echinacea purpurea . No correlation was found between the herbs inhibitory potentials towards CYP3A4 and P‐glycoprotein activities. Ginkgo biloba , horse chestnut and common sage, besides St. John's wort, are suggested candidates for in vivo intestinal herb‐drug pharmacokinetic interactions.